A biosimilar is a biologic
product that is similar to a regulatory body approved reference product, and
has no clinically meaningful differences in terms of safety and effectiveness
from that reference product. Only minor differences in clinically inactive
components are allowable in biosimilar products. The global biosimilars market
is expected to witness a steep growth owing to the patent expiry of blockbuster
biologic drugs. The ability of biosimilars to reduce healthcare costs is
another driving factor for this industry. Furthermore, the recent approval of
three biosimilars in the US market is providing an impetus to more
biopharmaceutical companies to enter this field.
View Full Report with TOC @ http://www.radiantinsights.com/research/global-biosimilar-market-outlook-2022
"Global Biosimilar Market
Outlook 2022", the global biosimilars market is anticipated to witness a
high double digit growth during 2016-2022. This report provides a detailed
analysis of the current and future market scenario of the global biosimilars
market. The report provides insight about the major drivers and challenges,
along with the latest trends and developments impacting the industry growth. In
addition, the report also highlights various opportunities available for growth
of the global biosimilars market.
The global biosimilars market has
been segmented on the basis of type of product. The major types of biosimilars
present in the market include monoclonal antibodies, erythropoietin, insulin,
G-CSF, HGH, and interferon amongst others. The report also highlights the
various biosimilar drugs available in the market, and the biosimilars currently
in various phases of clinical trials.
Request A Sample Copy of This Report at: http://www.radiantinsights.com/research/global-biosimilar-market-outlook-2022/request-sample
Furthermore, the global
biosimilars market has also been segmented on the basis of their applications.
According to the report, oncology is expected to account for the largest share
in 2016 due to presence of large number of biosimilars for this indication.
Based on geography, the report divides the market into Europe, Asia-Pacific,
North America and Rest of the World. In 2016, Europe is expected to account for
the largest share. Moreover, the report also lists down various mergers and
acquisitions taking place in the global biosimilars industry.
The last section of the report
discusses about the prominent players in global biosimilars market. Market
share analysis of these players is also provided in the report. A brief
business overview and financial information about each of these players has
been provided, along with their product portfolios and clinical pipelines. The
recent development of every player has also been presented in the report.
Overall, the research contains exhaustive information that will help clients in
formulating market strategies and assessing opportunity areas in the global
biosimilars market.
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to
meet their market research and business intelligence requirements. We assist
and facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant
Insights, Inc
Contact Person: Michelle
Thoras
Email:
sales@radiantinsights.com
Phone: (415) 349-0054
Address: 28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Comments
Post a Comment